KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity: 2010-2025

Historic Return on Equity for Emergent BioSolutions (EBS) over the last 15 years, with Sep 2025 value amounting to 0.14%.

  • Emergent BioSolutions' Return on Equity rose 60.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 60.00%. This contributed to the annual value of -0.34% for FY2024, which is 41.00% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Return on Equity stood at 0.14%, which was down 47.04% from 0.26% recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Return on Equity peaked at 0.26% during Q1 2021, and registered a low of -1.13% during Q4 2023.
  • Over the past 3 years, Emergent BioSolutions' median Return on Equity value was -0.47% (recorded in 2024), while the average stood at -0.51%.
  • As far as peak fluctuations go, Emergent BioSolutions' Return on Equity plummeted by 98bps in 2023, and later surged by 137bps in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Return on Equity stood at 0.14% in 2021, then declined by 29bps to -0.15% in 2022, then tumbled by 98bps to -1.13% in 2023, then skyrocketed by 75bps to -0.38% in 2024, then soared by 60bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q3 2025, 0.26% for Q2 2025, and -0.25% during Q1 2025.